Autologous stem cell transplantation as a care option in Waldenström's macroglobulinemia.


The optimal management of Waldenstrom's macroglobulinemia (WM) is in evolution, especially since the introduction of novel agents for its sister disease, multiple myeloma. Literature on the utility of autologous stem cell transplantation (ASCT) in WM, albeit mostly retrospective, supports its efficacy for symptomatic disease in eligible patients. Here, we… (More)
DOI: 10.3816/CLML.2011.n.032


1 Figure or Table

Slides referencing similar topics